Randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group Study (JCOG1407)

Category Primary study
JournalAnnals of Oncology
Year 2017
This article has no abstract
Epistemonikos ID: 17d753a30f22e3b00d369e1d23752d5e510abc9a
First added on: Feb 08, 2025